GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
about
Strategies to activate NK cells to prevent relapse and induce remission following hematopoietic stem cell transplantation.Natural Killer Cell Education and the Response to Infection and Cancer Therapy: Stay Tuned.Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review.MRI-guided interventional natural killer cell delivery for liver tumor treatment.Varicella zoster virus productively infects human natural killer cells and manipulates phenotype.Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells
P2860
GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
@en
type
label
GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
@en
prefLabel
GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
@en
P2093
P2860
P1433
P1476
GSK 3 inhibition drives maturation of NK cells and enhances their antitumor activity.
@en
P2093
Bahram Valamehr
Betsy Rezner
Bruce R Blazar
Daniel Shoemaker
Emily Taras
Frank Cichocki
Heinrich Schlums
Jeffrey S Miller
Katie Tuininga
P2860
P304
P356
10.1158/0008-5472.CAN-17-0799
P407
P577
2017-08-08T00:00:00Z